Notice: This company has been marked as potentially delisted and may not be actively trading. Centogene (CNTG) News Today Add Compare Share Share Headlines Stock AnalysisHeadlinesOwnershipShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period CENTOGENE Announces Voting Results of Extraordinary General MeetingDecember 4, 2024 | globenewswire.comCENTOGENE Signs Strategic Transaction With Private Equity Group Charme Capital PartnersNovember 13, 2024 | globenewswire.comCENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet NeurologySeptember 26, 2024 | finance.yahoo.comCENTOGENE Data on Novel Genetic Risk Factor for Parkinson's Disease in The Lancet NeurologySeptember 25, 2024 | globenewswire.comCNTGF Centogene N.V.September 7, 2024 | seekingalpha.comCentogene N.V. (CNTG)August 21, 2024 | finance.yahoo.comCentogene B V (CNTGF)August 15, 2024 | investing.comCENTOGENE Receives Delisting Notice From NasdaqAugust 7, 2024 | globenewswire.comCENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic FactorsAugust 2, 2024 | markets.businessinsider.comCENTOGENE Publication in Brain Journal Reveals 15% of Parkinson's Disease Cases Are Linked to Genetic FactorsAugust 1, 2024 | globenewswire.comC-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug DevelopmentJune 20, 2024 | globenewswire.comCENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General MeetingMay 31, 2024 | globenewswire.comCENTOGENE Reports Full Year 2023 Financial Results and Recent Business HighlightsMay 15, 2024 | globenewswire.comCENTOGENE Secures Approx. $20 Million to Strengthen Cash PositionMay 15, 2024 | globenewswire.comCENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher DiseaseMay 14, 2024 | globenewswire.comCentogene NV: CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsMay 10, 2024 | finanznachrichten.deCENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse PatientsMay 10, 2024 | globenewswire.comCentogene faces Nasdaq delisting over share priceApril 4, 2024 | investing.comCENTOGENE Receives Nasdaq Non-Compliance NoticeApril 2, 2024 | globenewswire.comCentogene (NASDAQ: CNTG)March 22, 2024 | fool.comCENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage DisordersMarch 19, 2024 | globenewswire.comCentogene NV: CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRa DeficiencyMarch 1, 2024 | finanznachrichten.deCENTOGENE scopre la carenza del recettore alfa delle cellule pre-TFebruary 29, 2024 | it.investing.comCENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα DeficiencyFebruary 29, 2024 | globenewswire.comCentogene NV: CENTOGENE Explores Strategic AlternativesFebruary 28, 2024 | finanznachrichten.deCentogene NV: CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingFebruary 28, 2024 | finanznachrichten.deCentogene Explores Strategic Alternatives, Incl. SaleFebruary 28, 2024 | markets.businessinsider.comCentogene Announces Receipt Of Nasdaq Notice Of DelistingFebruary 28, 2024 | markets.businessinsider.comCentogene to explores strategic alternatives, gets Nasdaq delisting notice; shares plungeFebruary 28, 2024 | msn.comCENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a HearingFebruary 28, 2024 | globenewswire.comCENTOGENE Explores Strategic AlternativesFebruary 28, 2024 | globenewswire.comCentogene NV: CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationJanuary 25, 2024 | finanznachrichten.deCENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research CollaborationJanuary 25, 2024 | finance.yahoo.comCentogene NV: CENTOGENE Receives French Research Tax Credit AccreditationJanuary 24, 2024 | finanznachrichten.deCENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using MultiomicsJanuary 23, 2024 | finance.yahoo.comCENTOGENE Announces Preliminary Full Year 2023 RevenueJanuary 18, 2024 | finance.yahoo.comCentogene NV Ordinary Shares CNTGDecember 21, 2023 | morningstar.comCentogene NV: CENTOGENE's Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment MilestoneDecember 13, 2023 | finanznachrichten.deMotus GI, C4 Therapeutics among healthcare moversDecember 13, 2023 | msn.comCCCC, XPOF and AUVI are among pre market gainersDecember 13, 2023 | msn.comCENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment MilestoneDecember 13, 2023 | finance.yahoo.comCentogene NV: CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture TransactionNovember 28, 2023 | finanznachrichten.deCENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture TransactionNovember 28, 2023 | finance.yahoo.comEVER, BIVI and CNTG among mid-day moversOctober 31, 2023 | msn.comH.C. Wainwright Keeps Their Buy Rating on Centogene NV (CNTG)September 15, 2023 | markets.businessinsider.comCENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 11, 2023 | finance.yahoo.comCENTOGENE Reports First Half 2023 Financial ResultsSeptember 7, 2023 | benzinga.comCentogene NV: CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares DeficiencySeptember 1, 2023 | finanznachrichten.deCENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease PatientsSeptember 1, 2023 | finance.yahoo.comCENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares DeficiencyAugust 31, 2023 | finance.yahoo.com Get Centogene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now CNTG Media Mentions By Week CNTG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTG News Sentiment▼0.000.60▲Average Medical News Sentiment CNTG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTG Articles This Week▼00▲CNTG Articles Average Week Get Centogene News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CCM News MRAI News PMD News TOI News BRTX News OPGN News KDLY News OTRK News MGRX News ATPC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTG) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centogene Please log in to your account or sign up in order to add this asset to your watchlist. Share Centogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CNTG Stock Alerts